• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	90,540	04.07.24 09:14:09	+0,300	+0,33%	90,300	90,370	90,520	90,240
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	944,800	04.07.24 08:04:14	+8,200	+0,88%	945,600	951,600	944,800	936,600